Advanced search
Publication Cover
Current Medical Research and Opinion Volume 28, 2012 - Issue 3
Submit an article Journal homepage
1,726
Views
37
CrossRef citations to date
0
Altmetric
Osteoporosis: Review

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

C. CooperMRC Lifecourse Epidemiology Unit, University of Southampton SouthamptonUK;Norman Collisson Chair of Musculoskeletal Sciences, NIHR Musculoskeletal Biomedical Research Unit, University of Oxford OxfordUK
,
J.-Y. ReginsterPublic Health and Health Economics, University of Liège LiegeBelgiumCorrespondence[email protected]
,
B. CortetDepartment of Rheumatology, University Hospital of Lille LilleFrance
,
M. Diaz-CurielServicio de Medicina Interna, Fundacion Jimenez Diaz, Universidad Autónoma MadridSpain
,
R.S. LorencThe Children’s Memorial Health Institute WarsawPoland
,
J.A. KanisWHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School SheffieldUK
&
R. RizzoliDivision of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospitals and Faculty of Medicine GenevaSwitzerland
 show all
Pages 475-491 | Accepted 27 Jan 2012, Published online: 23 Feb 2012

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Shu-Jyuan Yang, Chih-Hao Chang, Tai-Horng Young, Chung-Hao Wang, Tzu-Hao Tseng & Man-Ling Wang. (2022) Human serum albumin-based nanoparticles alter raloxifene administration and improve bioavailability. Drug Delivery 29:1, pages 2685-2693.
Read now
Jean-Yves Reginster, Franz Pelousse & Olivier Bruyère. (2013) Safety concerns with the long-term management of osteoporosis. Expert Opinion on Drug Safety 12:4, pages 507-522.
Read now
Patrizia D'Amelio & Giovanni Carlo Isaia. (2013) The use of raloxifene in osteoporosis treatment . Expert Opinion on Pharmacotherapy 14:7, pages 949-956.
Read now
R. Rizzoli, S. Boonen, M.-L. Brandi, O. Bruyère, C. Cooper, J.A. Kanis, J.-M. Kaufman, J.D. Ringe, G. Weryha & J.-Y. Reginster. (2013) Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Current Medical Research and Opinion 29:4, pages 305-313.
Read now

Articles from other publishers (33)

Xin Wan, Xuefei Wang, Ran Pang, Chunlei Xu, Wei Shi, Huafeng Zhang, Hui Li & Zhijun Li. (2022) Mapping knowledge landscapes and emerging trends of the links between osteoarthritis and osteoporosis: A bibliometric analysis. Frontiers in Public Health 10.
Crossref
René Rizzoli. 2022. Senior Trauma Patients. Senior Trauma Patients 107 119 .
Yasser El Miedany. 2022. New Horizons in Osteoporosis Management. New Horizons in Osteoporosis Management 491 524 .
Alexandros S. Zervas, Pavlos P. Lelovas, Antonios Galanos, Dimitrios Galanis, Maria Makropoulou, Stavros Beteinakis, Anastasia Patsaki, Christina Passali, Stavros K. Kourkoulis, Aggeliki Triantafyllou, Efstathios Chronopoulos, Alexios L. Skaltsounis & Ismene A. Dontas. (2021) The effect of table olive wastewater extract administration on the adult ovariectomised rat model of osteoporosis. British Journal of Nutrition 126:12, pages 1761-1770.
Crossref
Ying Han, Jielai Yang, Weiwei Zhao, Haimang Wang, Yulong Sun, Yuji Chen, Jing Luo, Lianfu Deng, Xiangyang Xu, Wenguo Cui & Hongyu Zhang. (2021) Biomimetic injectable hydrogel microspheres with enhanced lubrication and controllable drug release for the treatment of osteoarthritis. Bioactive Materials 6:10, pages 3596-3607.
Crossref
Foziyah Zakir, Adil Ahmad, Uzma Farooq, Mohd Aamir Mirza, Alok Tripathi, Divya Singh, Faiyaz Shakeel, Sradhanjali Mohapatra, Farhan J Ahmad & Kanchan Kohli. (2020) Design and development of a commercially viable in situ nanoemulgel for the treatment of postmenopausal osteoporosis . Nanomedicine 15:12, pages 1167-1187.
Crossref
René Rizzoli. (2018) Postmenopausal osteoporosis: Assessment and management. Best Practice & Research Clinical Endocrinology & Metabolism 32:5, pages 739-757.
Crossref
Tao Sun, Yulong Sun & Hongyu Zhang. (2018) Phospholipid-Coated Mesoporous Silica Nanoparticles Acting as Lubricating Drug Nanocarriers. Polymers 10:5, pages 513.
Crossref
Pernille Ravn Jakobsen, Anne Hermann, Jens Søndergaard, Uffe Wiil & Jane Clemensen. (2018) Development of an mHealth Application for Women Newly Diagnosed with Osteoporosis without Preceding Fractures: A Participatory Design Approach. International Journal of Environmental Research and Public Health 15:2, pages 330.
Crossref
C. Cooper, M. C. Schneider, M. K. Javaid, K. Åkesson, B. Dawson-Hughes, R. Rizzoli, J. A. Kanis & J. Y. Reginster. 2017. Orthogeriatrics. Orthogeriatrics 171 184 .
Susan R. Harris. (2016) Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer. Clinical Breast Cancer 16:6, pages 431-436.
Crossref
Chi-Chuan WangHsien-Tsung LuStacie B. DusetzinaChung-Hsuen Wu. (2016) The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis. Journal of Women's Health 25:7, pages 738-746.
Crossref
E. Sohl, R. T. de Jongh, K. M. A. Swart, A. W. Enneman, J. P. van Wijngaarden, S. C. van Dijk, A. C. Ham, N. L. van der Zwaluw, E. M. Brouwer-Brolsma, N. van der Velde, C. P. G. M. de Groot, S. J. te Velde, P. Lips & N. M. van Schoor. (2014) The Association Between Vitamin D Status and Parameters for Bone Density and Quality is Modified by Body Mass Index. Calcified Tissue International 96:2, pages 113-122.
Crossref
Yousef Al-Saleh, Riad Sulimani, Shaun Sabico, Hussein Raef, Mona Fouda, Fahad Alshahrani, Mohammad Al Shaker, Basma Al Wahabi, Mir Sadat-Ali, Hanan Al Rayes, Salwa Al Aidarous, Siham Saleh, Fakhr Al Ayoubi & Nasser M. Al-Daghri. (2015) 2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society. Annals of Saudi Medicine 35:1, pages 1-12.
Crossref
Ian J. Griffin. 2015. Nutrition and Bone Health. Nutrition and Bone Health 395 406 .
J.Y. Reginster, A. Neuprez, N. Dardenne, C. Beaudart, P. Emonts & O. Bruyere. (2014) Efficacy and safety of currently marketed anti-osteoporosis medications. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 809-834.
Crossref
Serge Ferrari. (2014) Future directions for new medical entities in osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 859-870.
Crossref
John A. Kanis & Mickaël Hiligsmann. (2014) The application of health technology assessment in osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism 28:6, pages 895-910.
Crossref
Axel Finckh & Kevin D. Deane. (2014) Prevention of Rheumatic Diseases. Rheumatic Disease Clinics of North America 40:4, pages 771-785.
Crossref
Tara L. Mader, Susan A. Novotny, Angela S. Lin, Robert E. Guldberg, Dawn A. Lowe & Gordon L. Warren. (2014) CCR2 Elimination in Mice Results in Larger and Stronger Tibial Bones but Bone Loss is not Attenuated Following Ovariectomy or Muscle Denervation. Calcified Tissue International 95:5, pages 457-466.
Crossref
R. Rizzoli, J. Branco, M.-L. Brandi, S. Boonen, O. Bruyère, P. Cacoub, C. Cooper, A. Diez-Perez, J. Duder, R. A. Fielding, N. C. Harvey, M. Hiligsmann, J. A. Kanis, J. Petermans, J. D. Ringe, Y. Tsouderos, J. Weinman & J.-Y. Reginster. (2014) Management of osteoporosis of the oldest old. Osteoporosis International 25:11, pages 2507-2529.
Crossref
C. Senn, B. Günther, A. W. Popp, R. Perrelet, D. Hans & K. Lippuner. (2014) Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporosis International 25:7, pages 1945-1951.
Crossref
M. Sosa Henríquez & M.J. Gómez de Tejada Romero. (2014) Tratamiento de la osteoporosis. Medicine - Programa de Formación Médica Continuada Acreditado 11:60, pages 3545-3554.
Crossref
Dominic Gröger, Michael Kerschnitzki, Marie Weinhart, Sabine Reimann, Tobias Schneider, Benjamin Kohl, Wolfgang Wagermaier, Gundula Schulze‐Tanzil, Peter Fratzl & Rainer Haag. (2013) Selectivity in Bone Targeting with Multivalent Dendritic Polyanion Dye Conjugates. Advanced Healthcare Materials 3:3, pages 375-385.
Crossref
A.-F. Donneau & J.-Y. Reginster. (2013) Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice. Osteoporosis International 25:2, pages 397-398.
Crossref
Erik F. Eriksen, Adolfo Díez-Pérez & Steven Boonen. (2014) Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review. Bone 58, pages 126-135.
Crossref
Swaran J.S. Flora. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 297 322 .
Boon Chin Heng, Dominique Aubel & Martin Fussenegger. (2013) An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology Advances 31:8, pages 1676-1694.
Crossref
Mickael Hiligsmann, John A. Kanis, Juliet Compston, Cyrus Cooper, Bruno Flamion, Pierre Bergmann, Jean-Jacques Body, Steven Boonen, Olivier Bruyere, Jean-Pierre Devogelaer, Stefan Goemaere, Jean-Marc Kaufman, Serge Rozenberg & Jean-Yves Reginster. (2013) Health Technology Assessment in Osteoporosis. Calcified Tissue International 93:1, pages 1-14.
Crossref
Luisella Cianferotti, Federica D’Asta & Maria Luisa Brandi. (2013) A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Therapeutic Advances in Musculoskeletal Disease 5:3, pages 127-139.
Crossref
M.-L. Brandi, J.-Y. Reginster, R. Rizzoli & J. B. Cannata-Andia. (2013) Comment on Freemantle et al.: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments. Osteoporosis International 24:6, pages 1929-1930.
Crossref
Jean-Yves Reginster, Franz Pelousse & Olivier Bruyère. (2013) Is there potential for strontium ranelate in the management of osteoarthritis?. Clinical Practice 10:2, pages 201-207.
Crossref
Jean-Yves Reginster & Olivier BruyèreChristopher R HolroydDarshan JagannathCyrus CooperNicholas C Harvey. 2013. Osteoporosis. Osteoporosis 56 69 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.